Upload
others
View
14
Download
0
Embed Size (px)
Citation preview
FEBRUARY 2020
ActivePharmaceutical
IngredientsCatalog
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
Canagli�ozin*
Dapagli�ozin*
Empagli�ozin*
Glimepiride
Linagliptin
PioglitazoneHydrochloride
SitagliptinHydrochloride
SitagliptinPhosphate
Abacavir Base
Gati�oxacin
Levo�oxacinHemihydrateMoxi�oxacin
Hydrochloride
Posaconazole
Terbina�neHydrochloride
Voriconazole
AmlodipineBesylate
Apixaban
AtorvastatinCalcium*
ClopidogrelBisulfate*
DabigatranEtexilate Mesylate
DoxazosinMesylate
EnalaprilMaleate
FondaparinuxSodium
Irbesartan
ANTI
-DIA
BETI
CCA
RDIO
VASC
ULAR
ANTI
-INF
ECTI
VE
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Nateglinide Available
Liraglutide UD
Semaglutide UD
LosartanPotassium Available
Iron Sucrose(Available for selected markets)
Lacidipine
Available
Available
MetoprololSuccinate Available
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
PrasugrelHydrochloride
Ramipril
Ranolazine
Rivaroxaban
Sacubitril /Valsartan
Telmisartan
Ticagrelor
Treprostinil
Valsartan
AsenapineMaleate
AtomoxetineHydrochloride
BenztropineMesylate
Dimethyl Fumarate
Divalproex Sodium
Donepezil HCl
EscitalopramOxalate
EslicarbazepineAcetate
Eszopiclone
FingolimodHydrochloride
Glatiramer Acetate
Levetiracetam
LurasidoneHydrochloride
MemantineHydrochloride
Olanzapine
CNS
CARD
IOVA
SCUL
AR
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Roxadustat UD
UD
Clopidogrel Form 2 UD
Ferric Carboxymaltose (Available for selected markets)
Ferumoxytol(Available for selected markets)
UD
UD
Pregabalin Available
Bempedoic Acid
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
QuetiapineFumarate
Risperidone
RivastigmineHydrogen Tartrat
TizanidineHydrochloride
VilazodoneHydrochloride
ZiprasidoneHydrochloride
EsomeprazoleMagnesium*
Famotidine
Lubiprostone
Nizatidine
Obeticholic Acid
Omeprazole
OmeprazoleMagnesium
PantoprazoleSodium
RabeprazoleSodium
Apremilast*
Estradiol
RaloxifeneHydrochloride
AbirateroneAcetate
Azacitidine
BendamustineHydrochloride
Bortezomib
Cabazitaxel
Capecitabine
Car�lzomib
ONCO
LOGY
GAST
RO-I
NTES
TINA
LCN
SM
USCU
LO-
SKEL
ETAL
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Siponimod UD
Edaravone UD
Linaclotide UD
Abaloparatide UD
Dasatinib(Available for selected markets) Available
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
Decitabine
Docetaxel
Enzalutamide
GemcitabineHydrochloride
Granisteron
IbandronateSodium
Ibrutinib*
Lenalidomide
Lenvatinib
Letrozole
Lomustine(Available for selected markets)
NilotinibHydrochloride
OndansetronHydrochloride
Palbociclib
PalonosetronHydrochloride
PemetrexedDisodium*
PemetrexedDitromethamine
Plerixafor
Pomalidomide
Venetoclax
Zoledronic Acid
Eribulin(Available for selected markets)
Fosaprepitant
Midostaurin
ONCO
LOGY
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
UD
UD
UD
UD
UD
UD
Apalutamide UD
Olaparib
Pazopanib
RuxolitinibPhosphate
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZILT H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
CetirizineDihydrochloride
Desloratadine
FexofenadineHydrochlorideLevocetirizine
Dihydrochloride
MontelukastSodium
Za�rlukast
Dutasteride
EliglustatHemitartrate*
Febuxostat
Finasteride
Mirabegron*
Testosterone
Icatibant Acetate
Li�tegrast
LorcaserinHydrochloride
Permethrin
SugammadexSodium
Pidotimod
CinacalcetHydrochloride
Elagolix Sodium
UROL
OGY
RESP
IRAT
ORY
OTHE
RS
KetorolacTromethamine
Naproxen
NaproxenSodium
NaratriptanHydrochloride
SumatriptanSuccinatePA
IN M
ANAG
EMEN
T
Available
Available
Available
Available
Available
UD
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
UD
UD
UD
UD
UD
Diroximel Fumarate
Lasmiditan
Tofacitinib
Varenicline Tartrate
February 2020
Disclaimer: No information in this catalog - including any reference to any product or service - constitutes an o�er for sale, or be construed as representing an o�er for sale. Products protected under valid patents are not o�ered or supplied for commercial use. However, the research quantities of such products may be o�ered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
OTHER PIPELINE PRODUCTS
Development timeline to be checked with the Sales Manager
PRODUCT NAMETHERAPY AREA DR. REDDY’S IP ORAL INJ
Dacomitinib
Erda�tinib
Encequidar Mesylate
Larotrectinib sulfate
Selinexor
ONCOLOGY
ONCOLOGY & OBSTETRICS/ GYNECOLOGY Relugolix
NASH
Filgotinib
Ela�branor
LumateperonePSYCHIATRY
AUTOIMMUNE/ IMMUNOLOGY